Document and Entity Information
Document and Entity Information | Jan. 19, 2024 |
Cover [Abstract] | |
Security Exchange Name | NASDAQ |
Amendment Flag | true |
Entity Central Index Key | 0001534133 |
Document Type | 8-K/A |
Document Period End Date | Jan. 19, 2024 |
Entity Registrant Name | CalciMedica, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39538 |
Entity Tax Identification Number | 45-2120079 |
Entity Address, Address Line One | 505 Coast Boulevard South |
Entity Address, Address Line Two | Suite 307 |
Entity Address, City or Town | La Jolla |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92037 |
City Area Code | (858) |
Local Phone Number | 952-5500 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.0001 per share |
Trading Symbol | CALC |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Description | This Amendment No. 1 on Form 8-K/A amends the Form 8-K filed by CalciMedica, Inc. (the “Company”) on January 22, 2024 (the “Original Report”) with the SEC to (i) correct the Purchase Price per Share (as defined below) and accompanying Common Warrants (as defined below) to $3.827 (or $3.8269 per Pre-Funded Warrant (as defined below) and accompanying Common Warrants, which represents the price of $3.827 per Share and accompanying Common Warrants minus the $0.0001 per share exercise price of each such Pre-Funded Warrant), (ii) correct the number of Shares, Pre-Funded Warrants, Common Warrants and Placement Agent Warrants (as defined below) being issued in the Private Placement to 4,985,610 Shares, 306,506 Pre-Funded Warrants, 5,292,116 Common Warrants and an aggregate of 75,747 Placement Agent Warrants and 75,746 Common Warrants to be issued to JonesTrading (as defined below), (iii) correct the aggregate gross proceeds that the Company has the potential to receive pursuant to the exercise of the Warrants (as defined below) to $33.1 million for an aggregate of up to approximately $54 million and (iv) refile Exhibit 10.1 to correct the foregoing amounts, as applicable. The other information disclosed in the Original Report is unchanged. The initial closing of the Private Placement closed on January 23, 2024. |